Explanation
Saxagliptin
nitspost-marketinacardiovascularendpointstudv.saxaajptin wasshowntobeassociated withincreased
incidenceof heart failure.Theaetiooqv isunclear.but wheretisseen.substitution with an alternativeis
advisable
@1MINENDOCRINE
